SELLAS Life Sciences (SLS) Operating Margin (2012 - 2022)
SELLAS Life Sciences (SLS) reported Operating Margin of 1673.5% for Q1 2022, down 163411.0% year-over-year from N/an in Q1 2021, and down 614.05% on a QoQ basis from 234.37% in Q2 2021.
SELLAS Life Sciences (SLS) has 7 years of Operating Margin data on file, last reported at 1673.5% in Q1 2022.
- Quarterly Operating Margin fell 163411.0% year-over-year to 1673.5% in Q1 2022, while the trailing twelve-month figure through Dec 2022 was 4195.0% (down 386218.0% YoY) and the FY2022 annual result came in at 4195.0%, down 386218.0% from the prior year.
- Operating Margin eased to 1673.5% in Q1 2022 per SLS's latest filing, from 234.37% in the prior quarter.
- Across five years, Operating Margin topped out at 39.39% in Q1 2021 and bottomed at 1673.5% in Q1 2022.
- The 3-year median for Operating Margin is 226.63% (2021), against an average of 541.54%.
- Peak annual rise in Operating Margin reached 163411 bps in 2022, while the deepest fall reached 163411 bps in 2022.
- Tracing SLS's Operating Margin over 3 years: stood at 218.89% in 2020, then declined by 7 bps to 234.37% in 2021, then plunged by 614 bps to 1673.5% in 2022.
- Per Business Quant, the three latest SLS Operating Margin figures stand at 1673.5% (Q1 2022), 234.37% (Q2 2021), and 39.39% (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -1,673.50% |
| Jun 30, 2021 | -234.37% |
| Mar 31, 2021 | -39.39% |
| Dec 31, 2020 | -218.89% |
| Jun 30, 2015 | -268.57% |
| Mar 31, 2015 | -324.07% |
| Dec 31, 2014 | -303.38% |
| Sep 30, 2014 | -652.28% |
| Jun 30, 2014 | -677.09% |
| Mar 31, 2014 | -545.28% |
| Dec 31, 2013 | -219.06% |
| Sep 30, 2013 | -425.49% |
| Jun 30, 2013 | -342.60% |
| Mar 31, 2013 | -304.23% |
| Dec 31, 2012 | 476.75% |
| Sep 30, 2012 | -472.48% |